Leprosy Bulletin 124

 

MESSAGE FROM THE AMBASSADOR

Persons affected by leprosy as partners in change

Last month, Nov. 19–23, I visited India, where more new cases of leprosy are detected per year than anywhere else in the world. Read More

50th Anniversary of WHO–TNF/SHF Partnership

With support, I embarked on a journey to reverse stigma and became an advocate

My introduction to Hansen’s disease happened when I was diagnosed with the illness in Laredo, Texas, in 1968 after many years of unexplained pain, blisters, and fevers. My diagnosis resulted in three traumatic events for me. Read more

NEXT GENERATION

An opportunity to strengthen myself as a person affected by Hansen’s disease and as a woman

My name is Luzia Alves. I am 35 years old, married, and a mother. I live in Teresina, the capital of the state of Piauí, Brazil. I am also a woman who has been cured of Hansen’s disease. This is my story. Read more

NEXT GENERATION

Taking on the responsibility of being a leader has changed me

I am Ashwini Pundalik Nannaware from Mohali Naleshwar village, Sindewahi block, Chandrapur district, Maharashtra state, India. I studied up to pre-degree (12 years of school) in arts, and I have a family of four: my husband, a son, a daughter, and myself. Read more

VIEWPOINT

Immune-mediated leprosy reactions before, during, and after multidrug therapy (MDT)

Leprosy, also known as Hansen disease, is a chronic infectious disease caused by Mycobacterium leprae (M. leprae) or, less commonly, Mycobacterium lepramatosis. Read more

AMBASSADOR’S JOURNAL

Goodwill Ambassador confirms value of supporting higher education for young adults from leprosy colonies during 4-day trip to India 

In November, WHO Goodwill Ambassador for Leprosy Elimination Yohei Sasakawa visited India’s capital city, New Delhi, for the first time in two years. Read more

INITIATIVE NEWS

Empowering persons affected by leprosy to know their rights and how to claim them

While we still lack systematic evidence that would enable us to identify good practices for eliminating discrimination on the grounds of leprosy in an accurate manner, tangible outcomes have surely resulted from access to justice and strategic litigation in at least three countries: Japan, India, and Brazil. Read more